home All News open_in_new Full Article

UTR Therapeutics Inc Announces IND submission to the US FDA for a First

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — UTR Therapeutics Inc (UTRx Inc.), a drug development biotech company based in New York City, USA is pleased to announce a new milestone, the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for UTRxM1-18, a novel therapeutic approach for […]


today 8 h. ago attach_file Society

attach_file Other
attach_file Other
attach_file Politics
attach_file Economics
attach_file Other
attach_file Other
attach_file Culture
attach_file Economics
attach_file Other
attach_file Economics
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Society
attach_file Other
attach_file Culture
attach_file Politics
attach_file Society
attach_file Other


ID: 505120913
Add Watch Country

arrow_drop_down